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Many patients die awaiting heart transplantation (CTX) due to a shortage of
donor hearts. There remains an urgent need to identify those at greatest risk
of dying during the waiting period so that priority for CTX can be optimally as-
signed. Because interlead variability of OT intervals (OT dispersion) has been
shown to identify arrhythmia or sudden death risk in certain populations,
this prospective study was undertaken to determine whether OT dispersion
might predict death in patients awaiting CTX. Of 108 consecutive patients
referred for CTX evaluation, 80 were placed on a waiting list, at which time a
standard 12-lead electrocardiogram (ECG) was recorded. OT dispersion was
measured as either the maximum-minimum OT interval (OTDISP) or as the
coefficient of variation of all OT intervals (OTCV). Patients were followed for
up to 25 months (mean time on waiting list 201 days). Annualized mortality
was 27% (7 heart failure and 7 sudden deaths), with 18% of patients dying
within 6 months. Using Cox regression analysis, only 3 variables identified at
the time of wait-listing predicted subsequent pre-transplant mortality; older
age (p < 0.04), OTDISP (p = 0.015) and OTCV (p = 0.004). Even the simplest
measurement of OT variability, (OTDISP), which could be rapidly obtained
from a standard 12-lead ECG, predicted a 4.5-fold increase in mortality in
those patients whose OTDISP exceeded 120 msec. (95% confidence inter-
val 1.1 to 17.8). Gender, etiology of heart failure, NYHA class, heart rate,
presence of a bundle branch block, or left ventricular ejection fraction (mean
19%) did not predict risk. Conclusion: Indices of OT dispersion provide a
powerful means to stratify a patient's risk of dying while awaiting CTX, and
may help to establish priority on a CTX waiting list.
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QT Dispersion Measured at the Time of Wait-Listing
is a Powerful Predictor of Who will Die Awaiting
Heart Transplantation
David J. Pinsky, Robert R. Sciacca, Jonathan S. Steinberg. Columbia University and
St. Luke 's-Roosevelt Hospital Center, New York, NY
As the waiting list for donor hearts increases, innovative ways to expand the
donor pool are being utilized. For urgent status I and older age recipients
(ages 60-70 years), we have been using donor hearts with normal left ven-
tricular function but with pre-existing coronary artery disease and performing
saphenous vein bypass grafts (SVG) at the time of transplantation. We now
report our short term results. Between March 1992 and June 1994, 10 pa-
tients (5 urgent status I with mean age 50.4 years and 5 older age patients
with mean age 65.4 years) underwent cardiac transplantation in our institu-
tion having either 1,2 or 3 SVGs performed at the time of transplant surgery.
The mean donor age was 54.2 years. Six of 10 patients have survived to 1
year with 3 early deaths and 1 late death due to infection (2 patients), rejec-
tion and early graft failure. Autopsies revealed all SVGs to be patent in all 4
patients. At the first year coronary angiogram, 9 of 10 SVGs (in 6 patients)
were found to be patent without significant stenoses present. Cardiac func-
tion at 1 year after transplant was as follows:
Average Cardiac Function at 1 year post OHT
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Outcome of Patients Transplanted with Bypassed
Donor Hearts
Hillel Laks, Davis Drinkwater, Jon A. Kobashigawa, Michael P. Gleeson. UCLA
Medical Center, Los Angeles, CA
The profound shortage of organ donors continues to fuel the search for other
methods to refurbish a failing heart. The use of transgenic cells transplanted
(Tx) in syngeneic rodents has shown modest success, but allogeneic and
xenogeneic transplants have not been uniformly successful. To assess the
feasibility of xenogeneic and allogeneic myoblast transplantation, six adult
swine underwent transplantation of murine atrial tumor cells (Xenogeneic)
and neonatal porcine myocytes (Allogeneic) into the left ventricular wall. Fol-
lowing general anesthesia, isolated cells were injected along the anterior and
posterior wall ofthe porcine left ventricle (six sites per animal). All the animals
were immunosuppressed with cyclosporine and prednisone and were fol-
lowed for 1 month post-injection and then sacrificed. Results are as follows:
In all 36 injected sites, the Tx cells proliferated within the host myocardium
with no significant rejection. CPK MB did not increase after the procedure
indicating that there was no damage to the host myocardium from the in-
jection of cells. Moreover, Tx cells formed close associations with host my-
ocytes that resembled intercalated discs on electron microscopy, and were
composed of PAN cadherin on immunofluorescent staining. These cells also
contained myofibrils and other cell architecture that resembled normal AT-l
or neonatal myocytes. Additionally, these cells produced angiogenic factors
resulting in a proliferation of the surrounding microvasculature. In conclu-
sion, these findings indicate successful xenogeneic and allogeneic myocyte
cell transplantation in a large animal model. These experiments set the stage
for future studies testing the ability of these cells to form a syncitium, con-
tract, and thereby "repair" a damaged heart.
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Successful Transplantation of Myoblasts into Adult
Porcine Myocardium: A Potential Method to Repair a
Failing Heart
Frank W. Smart, William Claycomb, Joseph DelCarpio, Duane Smith, Hector
O. Ventura, Mandeep R. Mehra, Dwight D. Stapleton, Helen DeGruiter, R.
Wayne Barbee, Clifford H. Van Meter. Ochsner MedicallnsMutions and Louisiana
State University School of Medicine, New Orleans, LA
was lower with TOHT vs SOHT at both time intervals (7 ± 4 vs 9 ± 4, P =
0.02 and 5 ± 2 vs 7 ± 3, P = 0.0006). Pulmonary arterial (PAM) and left atrial
mean pressure (PCWP) (mmHg) were similar at 2 weeks (21 ± 6 vs 23 ± 6,
P = NS; 12 ± 5 vs 13 ± 5, P = NS). At 6 months PAM was similar (20 ± 7
vs 22 ± 6, P ~ NS) but PCWP was lower in the TOHT group (11 ± 5 vs 13 ±
5, p = 0.045). Pulmonary vascular resistance (PVR, Wood-Units) was similar
at 2 weeks (16 ± 0.7 vs 1.9 ± 1.0, P = NS) and 6 months (1.6 ± 0.7 vs 1.7
± 1.0, P = NS). Heart rate (bpm) was higher at 2 weeks and 6 months with
TOHT than SOHT (84 ± 10 vs 75 ± 12, P = 0.0003 and 90 ± 12 vs 82 ± 9,
P = 0.0006). Conclusions: Despite a longer ischemic time, total orthotopic
heart transplantation does not impair postoperative cardiac function. There
is an early improvement in cardiac output, a sustained higher heart rate re-
flecting preservation of donor sinus node function, and a lower RA pressure,
perhaps due to less tricuspid regurgitation.
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Induction of Inducible Nitric Oxide Synthase (iNOS)
mRNA and Protein in the Human Cardiac Allograft is
Associated with Increased Myocardial cGMP Levels
and Echocardiographlc LV Dysfunction
Neil P. Lewis, Philip S. Tsao, Peter R. Rickenbacher, Guy A. Haywood, Heiko von
der Leyen, Sharon A. Hunt. Margaret E. Billingham 1, Hannah A. Valantine, Michael
B. Fowler. Cardiovascular Medicine, Stanford University, Stanford, CA; 1Pathology,
Stanford University, Stanford, CA
In humans the mechanisms underlying LV contractile dysfunction following
cardiac transplantation remain poorly defined. iNOS is expressed in the rat
heterotopic cardiac allograft during rejection; the resultant overproduction
of nitric oxide (NO) might contribute to cardiac contractile dysfunction via
cGMP-mediated negative inotropic actions, or by the cytotoxic actions of
NO. We therefore prospectively studied 16 patients at surveillance endomy-
ocardial biopsy during the first year posttransplant - a total of 123 biopsies
(4-12 sequential per patient). iNOS mRNA was detected by reverse transcrip-
tion PCR in biopsy allograft myocardium in every patient, and in 59/123 (48%)
biopsies overall. iNOS mRNA expression was episodic and time dependent;
expression was most frequent during the first 180 days posttransplant (p =
0.0006). iNOS expression was not related to the ISHLT histologic grade of re-
jection. iNOS protein was detected by immunofluorescence in the coronary
microvasculature and in cardiac myocytes; expression was associated with
increased myocardial cGMP levels (p = 0.01) and with systolic (p = 0.024)
and diastolic (p = 0.006) left ventricular contractile dysfunction measured by
echocardiography and Doppler.
Conclusion. These data support a causal relationship between iNOS ex-
pression and myocardial contractile dysfunction in the human cardiac allo-
graft.
Conclusion: Patients transplanted with bypassed donor hearts appear to
have normal cardiac function and acceptable short term survival considering
their preop high risk status. A majority of SVGs remain patent at 1 year with
coronary ischemia not appearing to be responsible for early mortality.
Intracoronary/lntravascular Ultrasound
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1734-1 I Interim Analysis of the EPISODE Trial
Elma J. Gussenhoven, EPISODE study group. University Hospital Rotterdam-Dijkzigt
The Netherlands Heart Foundation and the Interuniversity Cardiology Institute, The
Netherlands
Application of intravascular ultrasound (IVUS) is evolved rapidly and now we
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have a better insight in the mechanism of balloon angioplasty (PTA) of the
superficial femoral artery (SFA). The EPISODE trial (Evaluation Peripheral In-
travascular Sonography on Dotter Effect) is a multicenter study evaluating
whether IVUS is a better predictor of the outcome after PTA of the SFA than
standard angiography. We studied 41 patients (pts) with angiographic suc-
cessful PTA (26 M, 15 F; mean age 70 ± 8 yr). Of each patient, the smallest
free lumen area seen on IVUS before and after PTA was selected. Oualitative
analysis included lesion morphology and geometry before PTA and dissec-
tion, plaque rupture and internal elastic lamina rupture after PTA. Quantitative
analysis included free lumen area (FLAl. free lumen diameter (FLO), media-
bounded area (MBA) and percentage area stenosis (%S) before and after
PTA. Success or failure at 1 month and at 6 months was defined using a
combination of clinical and objective vascular laboratory criteria, including
anklelbrachial index and duplex.
At one month success of PTA was evidenced in 30 pts and failure in 11
pts. After 6 months success was seen in 19 pts (46%; Group I) and failure in
22 pts (54%; Group II). No differences in outcome could be demonstrated on
the basis of qualitative IVUS findings before and after PTA. Quantitative data
before PTA of both groups were not significantly different. After PTA both
groups showed a significant increase in FLA and FLO and a significant de-
crease in %S. Significant differences were encountered between the Group
I and II for FLA (13.0 vs 9.7 mm2 and FLO (4.0 vs 3,5 mml. whereas no sig-
nificant differences were encountered in MBA and %S.
Conclusion: The present study indicates for the first time that the presence
of a narrow free lumen site within the lumen evidenced by IVUS following
PTA is the most common mechanism underlying restenosis. Given the high
incidence of failures seen at 1 month it is likely that rest-stenosis rather than
restenosis may be the underlying mechanism to the failures evidenced.
definitively established. Data was collected from multiple European centers
performing intracoronary ultrasound examinations under the auspices of the
SUbgroup on Intravascular Ultrasound of the Working Group on Echocardiog-
raphy of the European Society of Cardiology. Information was obtained about
the number of exams performed. complications related to imaging. patient's
age and CAD risk factors, indication for exam, concomitant procedures per-
formed, catheter size and location. and any adverse clinical consequences
related to ICUS imaging. Twelve centers (mean 59 patients. range 3-140) sub-
mitted information about their experience with ICUS. A total of eight (1.1 %)
complications were reported in a total of 718 examinations. All complica-
tions occurred during ICUS exams in patients with atherosclerotic coronary
disease with a diagnosis of unstable or stable angina who underwent PTCA.
Four cases of transient vessel spasm were seen, all of which resolved after
administration of nitroglycerin. Two cases of vessel dissection were noted
when imaging after PTCA. and thought to be "possibly" related to the ul-
trasound catheter. Two cases of guidewire entrapment after distal advance-
ment of the transducer were reported. requiring the catheter and guidewire
to be withdrawn. No adverse clinical consequences due to ICUS imaging
were reported. There was no difference in frequency of complications be-
tween centers assessed by Chi square (p = 0.232).
Conclusion: Intracoronary ultrasound examinations can be performed
safely with a very low rate of acute complications.
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1734-41 Can Intracoronary Ultrasound Improve PTCA
Results?: Preliminary Core Lab Ultrasound Analysis
from the CLOUT Pilot Study
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1734-21 Prognostic Significance of Left Main Coronary Artery
Disease Detected by Intravascular Ultrasound
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1734-31 The Safety of Intracoronary Ultrasound: Data from a
Multicenter European Registry
John MeB. Hodgson, Gregg W. Stone, Fred G. SI. Goar. Thomas Linnemeier.
Helen Sheehan, CLOUT investigators. University Hospitals of Cleveland. Cleveland.
OH; EI Camino Hospital, Mt. View, CA
The CLOUT Pilot Study hypothesis is that intracoronary ultrasound (ICUS)
guidance can maximize the potential of balloon angioplasty through the safe
application of carefully chosen oversized balloons. PTCA was performed un-
til success was obtained using standard angiographic criteria. ICUS was then
performed and. based on the degree of reference segment disease, balloons
were upsized from 0.25 to 0.75 mm (mean 0.4 mm) regardless of the angio-
graphic results. There have been no complications using this strategy in the
initial 14 of a planned 100 patients. ICUS measures were performed using
semiautomated programs at a core laboratory.
Results; In the reference segment. ICUS revealed a mean lumen diameter
of 2.60 ± 0.35 mm and plaque thickness of 0.78 ± 0.11 mm; on average
54.75 ± 11.05% of the reference vessel was occupied by atheroma. At ini-
tial ICUS evaluation after angiographically successful PTCA, the lesion had a
minimal lumen diameter (MLD) of 1.78 ± 0.22 mm and lumen area of 3.14 ±
0.88 mm2 Following balloon upsizing, the lesion MLD increased to 1.95 ±
0.15 mm (8.7% gain, p < 0.02) and lumen area to 3.76 ± 0.63 mm2 (16.7%
gain, p < 0.01). When compared to the reference segment lumen area. the
lesional %Iumen area reduction improved from 38.14 ± 16.74% to 25.91 ±
12.17% (p < 0.01). Lumen improvement occurred primarily by expansion of
the total vessel area (12.08 ± 3.01 mm2 to 12.51 ± 3.11 mm2 , p = ns). As
expected, there was a large degree of residual atheroma (68.62 ± 7.47%
cross sectional narrowing). After routine PTCA. only 5 of 12 patients reached
a target MLD of 75% of the reference lumen diameter. Following balloon
upsizing, 8 of 12 had reached this criteria.
Conclusions: ICUS guided balloon upsizing based on the degree of refer·
ence segment disease may be safely performed and results in significant
improvement in luminal cross sectional area above that achieved byangio-
graphic guidance alone. This may potentially lower restenosis rates if these
initial gains are sustained long term.
Javier GOleolea, Lourdes Arganda, Fernando Alfonso, Rosana Hernandez,
Javier Segovia. Adolfo Rodriguez, Carlos Maeaya. Hospital Universitario San Carlos,
Madrid. Spain
Radiofrequency thermal balloon angioplasty (RF) may be performed with
very low balloon pressures, decreasing barotrauma, and a lower incidence
of dissections has been reported. In order to study the mechanism responsi-
ble for dilation after RF. we have imaged with intracoronary ultrasound (ICUS)
[mechanically rotated transducer; 20-30 MHz; 3.5--4.8F], 12 lesions, of a to-
tal of 31 included in a prospective protocol designed to evaluate the use-
fulness of RF. In 11/12 lesions we were able to obtain interpretable images,
and these are the subject of our study. In 9/11 (81 %) of the lesions, imag-
ing was attempted both before (pre). and after (Post) RF and in 2 the ICUS
catheter could not cross the lesion previous to RF. Plaque on IVUS was con-
sidered hypoechogenic (n = 4, 36%). fibrotic (n = 4, 36%) or calcified (n =
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1734-51 Mechanims of Radiofrequency Thermal Balloon
Angioplasty. A StUdy with Intracoronary Ultrasound
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William B. Burns, James B. Hermiller, Katherine B. Kisslo, Stephen C. Culp, Charles
J. Davidson. Northwestern Univ. Chicago, IL; Duke Univ. Durham. NC
Intracoronary ultrasound (ICUS) has detected left main coronary artery
(LMCA) disease that is silent by contrast angiography. The prognostic im-
portance of ICUS detected LMCA disease is unknown. To determine the
long-term outcome of LMCA disease detected by ICUS, long-term clinical
followup was obtained in 30 consecutive patients. ICUS LMCA evaluation
was performed immediately following successful PTCA of the LAD or LCX.
Mean followup was 3 years (range 2--4 yrs). ICUS and quantitative angiog-
raphy were analyzed for predictors of clinical outcome. Angiographically, 21
patients had normal LMCA and 9 were insignificantly abnormal; by ICUS 23
had >20% area stenosis. Major cardiovascular (CV) events occurred in 9, in-
cluding 6 CABG, 2 cardiac deaths and 1 MI. No significant difference in age,
LVEF, number or location of arteries involved were noted between those with
and without events.
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Conclusions: ICUS may predict cardiovascular prognosis in patients with
angiographically silent LMCA disease. Patients with ICUS determined left
main area stenosis >20% appear to have a higher incidence of major clinical
cardiovascular events at long-term followup.
Braden W. Batkoff, David 1 Linker. University of Washington. Seattle. WA
The clinical use of intracoronary ultrasound (ICUS) is growing, serving as a
useful adjuvant to contrast angiography, and providing additional information
to assist with catheter based interventions. Despite the increasing use of this
technique, it remains an invasive procedure which the safety has not been
